268.04
前日終値:
$271.12
開ける:
$269.59
24時間の取引高:
900.09K
Relative Volume:
1.05
時価総額:
$22.22B
収益:
$13.48B
当期純損益:
$764.50M
株価収益率:
29.56
EPS:
9.0688
ネットキャッシュフロー:
$1.26B
1週間 パフォーマンス:
-0.41%
1か月 パフォーマンス:
+5.57%
6か月 パフォーマンス:
+2.35%
1年 パフォーマンス:
+7.86%
Labcorp Holdings Inc Stock (LH) Company Profile
LH を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
LH
Labcorp Holdings Inc
|
268.04 | 22.48B | 13.48B | 764.50M | 1.26B | 9.0688 |
|
TMO
Thermo Fisher Scientific Inc
|
608.02 | 234.41B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
224.54 | 166.52B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
687.74 | 55.48B | 4.17B | 1.03B | 940.22M | 12.61 |
|
IQV
Iqvia Holdings Inc
|
239.76 | 41.05B | 15.90B | 1.28B | 2.21B | 7.2842 |
|
A
Agilent Technologies Inc
|
133.87 | 38.54B | 6.95B | 1.30B | 1.15B | 4.5696 |
Labcorp Holdings Inc Stock (LH) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-10 | ダウングレード | HSBC Securities | Buy → Hold |
| 2025-04-02 | 開始されました | Redburn Atlantic | Buy |
| 2025-03-04 | アップグレード | Citigroup | Neutral → Buy |
| 2025-01-07 | アップグレード | Evercore ISI | In-line → Outperform |
| 2024-12-10 | 再開されました | Jefferies | Buy |
| 2024-10-30 | アップグレード | HSBC Securities | Hold → Buy |
| 2024-10-01 | 開始されました | Piper Sandler | Neutral |
| 2024-03-25 | アップグレード | Argus | Hold → Buy |
| 2024-02-26 | 開始されました | Leerink Partners | Outperform |
| 2024-02-09 | 開始されました | Evercore ISI | In-line |
| 2024-01-03 | 開始されました | Barclays | Equal Weight |
| 2023-09-06 | 開始されました | HSBC Securities | Hold |
| 2022-12-12 | ダウングレード | Citigroup | Buy → Neutral |
| 2022-09-19 | ダウングレード | Argus | Buy → Hold |
| 2022-08-22 | 再開されました | Morgan Stanley | Overweight |
| 2022-01-28 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2021-01-11 | アップグレード | Argus | Hold → Buy |
| 2021-01-11 | ダウングレード | Wolfe Research | Peer Perform → Underperform |
| 2021-01-08 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2020-07-14 | アップグレード | BofA Securities | Neutral → Buy |
| 2020-07-13 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2020-06-02 | 再開されました | Deutsche Bank | Buy |
| 2020-05-15 | アップグレード | Mizuho | Neutral → Buy |
| 2020-04-29 | ダウングレード | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-04-27 | アップグレード | Citigroup | Neutral → Buy |
| 2020-04-27 | アップグレード | Wolfe Research | Underperform → Peer Perform |
| 2020-01-08 | 開始されました | Wells Fargo | Overweight |
| 2019-07-16 | アップグレード | BofA/Merrill | Underperform → Neutral |
| 2019-06-21 | アップグレード | Deutsche Bank | Hold → Buy |
| 2019-04-02 | アップグレード | Jefferies | Hold → Buy |
| 2019-01-17 | 開始されました | UBS | Buy |
| 2019-01-03 | ダウングレード | BofA/Merrill | Neutral → Underperform |
| 2018-12-03 | ダウングレード | Craig Hallum | Buy → Hold |
| 2018-10-30 | ダウングレード | Argus | Buy → Hold |
| 2018-10-25 | ダウングレード | Canaccord Genuity | Buy → Hold |
| 2018-10-19 | 再開されました | BofA/Merrill | Buy |
| 2018-06-07 | アップグレード | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2018-05-01 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2018-03-23 | 開始されました | Argus | Buy |
すべてを表示
Labcorp Holdings Inc (LH) 最新ニュース
Labcorp Holdings Inc. $LH Stake Reduced by Cambiar Investors LLC - MarketBeat
What Makes Labcorp (LH) a New Buy Stock - sharewise.com
Labcorp Holdings Inc. $LH Shares Sold by Cooke & Bieler LP - MarketBeat
Sector Gamma AS Acquires 6,486 Shares of Labcorp Holdings Inc. $LH - MarketBeat
Strs Ohio Reduces Stake in Labcorp Holdings Inc. $LH - MarketBeat
Labcorp Holdings Inc. (NYSE:LH) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Labcorp (NYSE:LH) Upgraded to Buy at Wall Street Zen - MarketBeat
Expanded MRD Test Suite and Dividend Hike Might Change The Case For Investing In Labcorp (LH) - simplywall.st
QRG Capital Management Inc. Has $878,000 Stock Holdings in Labcorp Holdings Inc. $LH - MarketBeat
The Price Is Right For Labcorp Holdings Inc. (NYSE:LH) - 富途资讯
Labcorp Holdings Inc. $LH Shares Sold by Massachusetts Financial Services Co. MA - MarketBeat
Navera Investment Management Ltd. Sells 11,643 Shares of Labcorp Holdings Inc. $LH - MarketBeat
Community Health Completes Asset Sale to LabCorp - MSN
Labcorp Holdings' (NYSE:LH) Dividend Will Be $0.72 - simplywall.st
Labcorp Holdings (NYSE:LH) Has Announced A Dividend Of $0.72 - Yahoo Finance
Campbell & CO Investment Adviser LLC Invests $1.97 Million in Labcorp Holdings Inc. $LH - MarketBeat
Ideas Watch: Can Labcorp Holdings Inc disrupt its industryPrice Action & Daily Growth Stock Tips - baoquankhu1.vn
Labcorp to Settle Patient Privacy Dispute Over Online Trackers - Bloomberg Law News
Manning & Napier Advisors LLC Decreases Stock Position in Labcorp Holdings Inc. $LH - MarketBeat
Labcorp’s quarterly earnings preview: What you need to know - MSN
Is Labcorp (LH) Quietly Reframing Its Oncology Innovation Story With Dividends And MRD Expansion? - Yahoo Finance
Labcorp Holdings Board Declares Quarterly Cash Dividend - The Globe and Mail
Labcorp Schedules Q4 2025 Earnings Release and Call - TipRanks
Labcorp to Announce Fourth Quarter Financial Results on February 17, 2026 - Finviz
Labcorp Holdings Inc to Announce Q4 2025 Financial Results - TradingView — Track All Markets
A Look At Labcorp (LH) Valuation After Expanding Its MRD Cancer Testing Portfolio - Sahm
Labcorp Declares Quarterly Dividend - Sahm
Labcorp declares quarterly dividend of $0.72 per share By Investing.com - Investing.com Nigeria
Labcorp Holdings Inc. to Issue Quarterly Dividend of $0.72 (NYSE:LH) - MarketBeat
Press Release: Labcorp Declares Quarterly Dividend - 富途牛牛
Baird Adjusts Labcorp Price Target to $313 From $307, Maintains Outperform Rating - marketscreener.com
Labcorp Holdings Inc. Declares Quarterly Dividend, Payable on March 12, 2026 - marketscreener.com
Labcorp Holdings Maintains Quarterly Dividend of $0.72 a Share, Payable March 12 to Shareholders of Record as of Feb. 27 - marketscreener.com
Labcorp declares quarterly dividend of $0.72 per share - Investing.com
Labcorp’s Expanded Plasma Detect MRD Portfolio Could Be A Game Changer For Labcorp Holdings (LH) - Sahm
Labcorp expands cancer recurrence testing for breast, lung, colon cancers By Investing.com - Investing.com Canada
Labcorp expands cancer recurrence testing for breast, lung, colon cancers - Investing.com
Labcorp Expands MRD Testing for Breast, Lung and Colon Cancer Recurrence Risk - Finviz
Labcorp Holdings Inc. $LH Shares Sold by Nordea Investment Management AB - MarketBeat
Labcorp Expands MRD Testing for Breast, Lung and Colon Cancer Recurrence Risk (2026-01-13) - Seeking Alpha
Assessing Labcorp Holdings (LH) Valuation After A Recent 10.5% Three Month Share Price Decline - Yahoo Finance
Best Testosterone Replacement Therapy (TRT) 2026: Taurus Meds Consumer Analysis Examines Online TRT Access and At-Home Testosterone Treatment Options - GlobeNewswire Inc.
SG Americas Securities LLC Acquires 17,723 Shares of Labcorp Holdings Inc. $LH - MarketBeat
Labcorp (LH) Up 8.1% Since Last Earnings Report: Can It Continue? - MSN
Will Labcorp Holdings Inc. stock outperform tech sector in 2025Market Risk Summary & Community Supported Trade Ideas - Улправда
Labcorp Holdings Inc. $LH Shares Sold by Cerity Partners LLC - MarketBeat
Labcorp (NYSE:LH) Downgraded by Wall Street Zen to "Hold" - MarketBeat
Labcorp’s Quarterly Earnings Preview: What You Need to Know - Yahoo Finance
NAMSA acquires Labcorp’s medical device testing assets - Yahoo Finance
Is Labcorp Holdings Inc. stock worth holding before Fed meetingMarket Risk Summary & Growth Focused Entry Reports - ulpravda.ru
Is Labcorp Holdings Inc. stock supported by strong cash flowsBreakout Watch & Weekly High Return Forecasts - ulpravda.ru
Labcorp Holdings Inc (LH) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):